⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5831129 | 0.96 | — | — | |
| SCHEMBL28780992 | 0.72 | HIF1A (0.32) | — | |
| SCHEMBL6261398 | 0.72 | — | — | |
| SCHEMBL3756782 | 0.72 | — | — | |
| SCHEMBL3751873 | 0.72 | — | — | |
| SCHEMBL7749247 | 0.72 | — | — | |
| SCHEMBL7694723 | 0.69 | HIF1A (0.30) | — | |
| SCHEMBL8157612 | 0.67 | — | — | |
| SCHEMBL9735016 | 0.67 | — | — | |
| SCHEMBL29068859 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1043 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209016-A1 | FLUORESCENT NUCLEOSIDE PHOSPHATES | STEALTH LABELS BIOTECH AB (SE) | 2024-06-27 | — | — | US | claimed |
| EP-4323373-A1 | FLUORESCENT NUCLEOSIDE PHOSPHATES | STEALTH LABELS BIOTECH AB (SE) | 2024-02-21 | — | — | EP | claimed |
| US-20230219995-A1 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | STEALTH LABELS BIOTECH AB (SE) | 2023-07-13 | — | — | US | claimed |
| EP-4172170-A1 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | STEALTH LABELS BIOTECH AB (SE) | 2023-05-03 | — | — | EP | claimed |
| WO-2021260107-A1 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | STEALTH LABELS BIOTECH AB (SE) | 2021-12-30 | — | — | WO | claimed |
| US-20210087165-A1 | PROCESS OF MAKING SOMATOSTATIN MODULATORS | Crinetics Pharmaceuticals, Inc. | 2021-03-25 | — | — | US | claimed |
| EP-3740475-A1 | PROCESS OF MAKING SOMATOSTATIN MODULATORS | Crinetics Pharmaceuticals, Inc. (US) | 2020-11-25 | — | — | EP | claimed |
| CN-111868049-A | Methods of making somatostatin modulators | 克林提克斯医药股份有限公司 | 2020-10-30 | — | — | CN | claimed |
| EP-3274358-B1 | VACCINE AGAINST CARBAPENEM-RESISTANTKLEBSIELLA PNEUMONIAE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS EV (DE) | 2020-09-16 | — | — | EP | claimed |
| US-20200048219-A1 | PROCESS OF MAKING SOMATOSTATIN MODULATORS | Crinetics Pharmaceuticals, Inc. | 2020-02-13 | — | — | US | claimed |
| US-6242638-B1 | FIREPROOFING USING CURED MIXTURES | VANTICO INC. | 2001-06-05 | — | — | US | claimed |
| US-6184376-B1 | POTENT ANTIVIRALS, ESPECIALLY AGAINST HERPES INFECTIONS, SUCH AS THOSE CAUSED BY VARICELLA ZOSTER VIRUS, HERPES SIMPLEX, EPSTEIN-BARR VIRUS, HERPES TYPE 6 (HHV-6) AND TYPE 8 (HHV-8). SHINGLES IN THE ELDERLY OR CHICKEN POX IN THE YOUNG | MEDIVER AB (SE) | 2001-02-06 | — | — | US | claimed |
| EP-1042317-A1 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | AstraZeneca AB (SE) | 2000-10-11 | — | — | EP | claimed |
| WO-2000055123-A1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | VANTICO AG (CH) | 2000-09-21 | — | — | WO | claimed |
| WO-1999032483-A1 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | ASTRAZENECA AB (SE) | 1999-07-01 | — | — | WO | claimed |
| EP-0296749-A1 | (Substituted aralkyl) heterocyclic compounds | ZENECA LIMITED (GB) | 1988-12-28 | — | — | EP | claimed |
| US-4458089-A | ANTITUMOR AGENTS, MICROBIOCIDES | THE UPJOHN COMPANY (US) | 1984-07-03 | — | — | US | claimed |
| US-4107432-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1978-08-15 | — | — | US | claimed |
| US-4063015-A | BACTERICIDE | SCHERING CORPORATION (US) | 1977-12-13 | — | — | US | claimed |
| US-4058661-A | 7-Diacyl cephalosporins | MERCK & CO., INC. (US) | 1977-11-15 | — | — | US | claimed |